Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice

Hyun Kim Dong, Hee Yoo Keon, Sook Yim Young, Jaewon Choi, Hyun Lee Soo, Lim Jung Hye, Woong Sung Ki, Sung Eun Yang, Il Oh Won, Yoon Sun Yang, Sang Hee Kim, Sang-Yun Choi, Hoe Koo Hong

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Transplantation of marrow-derived mesenchymal stem cells (MSCs), expanded by culture in addition to whole bone marrow, has been shown to enhance engraftment of human hematopoietic stem cells (HSCs). Our hypothesis was that there might be an optimum ratio range that could enhance engraftment. We examined the percent donor chimerism according to the ratio of HSCs to MSCs in non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. We tested a series of ratios of co-transplanted CD34+-selected bone marrow cells, and marrow-derived MSCs into sublethally irradiated NOD/SCID mice. In all experiments, 1 × 105 bone marrow derived human CD34 + cells were administered to each mouse and human MSCs from different donors were infused concomitantly. We repeated the procedure three times and evaluated engraftment with flow cytometry four weeks after each transplantation. Serial ratios of HSCs to MSCs were 1:0, 1:1, 1:2 and 1:4, in the first experiment, 1:0, 1:1, 1:2, 1:4 and 1:8 in the second and 1:0, 1:1, 1:4, 1:8 and 1:16 in the third. Cotransplantation of HSCs and MSCs enhanced engraftment as the dose of MSCs increased. Our results suggest that the optimal ratio of HSCs and MSCs for cotransplantation might be in the range of 1:8-1:16; whereas, an excessive dose of MSCs might decrease engraftment efficiency.

Original languageEnglish
Pages (from-to)1000-1004
Number of pages5
JournalJournal of Korean Medical Science
Volume21
Issue number6
Publication statusPublished - 2006 Dec 1

Fingerprint

Severe Combined Immunodeficiency
Hematopoietic Stem Cells
Mesenchymal Stromal Cells
Bone Marrow
Transplantation
Chimerism
Bone Marrow Cells
Flow Cytometry
Cell Culture Techniques

Keywords

  • Engraftment
  • Hematopoietic stem cells
  • Mesenchymal stem cells
  • Mice, SCID
  • Transplantation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice. / Dong, Hyun Kim; Keon, Hee Yoo; Young, Sook Yim; Choi, Jaewon; Soo, Hyun Lee; Hye, Lim Jung; Ki, Woong Sung; Yang, Sung Eun; Won, Il Oh; Yang, Yoon Sun; Kim, Sang Hee; Choi, Sang-Yun; Hong, Hoe Koo.

In: Journal of Korean Medical Science, Vol. 21, No. 6, 01.12.2006, p. 1000-1004.

Research output: Contribution to journalArticle

Dong, HK, Keon, HY, Young, SY, Choi, J, Soo, HL, Hye, LJ, Ki, WS, Yang, SE, Won, IO, Yang, YS, Kim, SH, Choi, S-Y & Hong, HK 2006, 'Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice', Journal of Korean Medical Science, vol. 21, no. 6, pp. 1000-1004.
Dong, Hyun Kim ; Keon, Hee Yoo ; Young, Sook Yim ; Choi, Jaewon ; Soo, Hyun Lee ; Hye, Lim Jung ; Ki, Woong Sung ; Yang, Sung Eun ; Won, Il Oh ; Yang, Yoon Sun ; Kim, Sang Hee ; Choi, Sang-Yun ; Hong, Hoe Koo. / Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice. In: Journal of Korean Medical Science. 2006 ; Vol. 21, No. 6. pp. 1000-1004.
@article{d915243257c64b7fac379b3ee54d0af1,
title = "Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice",
abstract = "Transplantation of marrow-derived mesenchymal stem cells (MSCs), expanded by culture in addition to whole bone marrow, has been shown to enhance engraftment of human hematopoietic stem cells (HSCs). Our hypothesis was that there might be an optimum ratio range that could enhance engraftment. We examined the percent donor chimerism according to the ratio of HSCs to MSCs in non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. We tested a series of ratios of co-transplanted CD34+-selected bone marrow cells, and marrow-derived MSCs into sublethally irradiated NOD/SCID mice. In all experiments, 1 × 105 bone marrow derived human CD34 + cells were administered to each mouse and human MSCs from different donors were infused concomitantly. We repeated the procedure three times and evaluated engraftment with flow cytometry four weeks after each transplantation. Serial ratios of HSCs to MSCs were 1:0, 1:1, 1:2 and 1:4, in the first experiment, 1:0, 1:1, 1:2, 1:4 and 1:8 in the second and 1:0, 1:1, 1:4, 1:8 and 1:16 in the third. Cotransplantation of HSCs and MSCs enhanced engraftment as the dose of MSCs increased. Our results suggest that the optimal ratio of HSCs and MSCs for cotransplantation might be in the range of 1:8-1:16; whereas, an excessive dose of MSCs might decrease engraftment efficiency.",
keywords = "Engraftment, Hematopoietic stem cells, Mesenchymal stem cells, Mice, SCID, Transplantation",
author = "Dong, {Hyun Kim} and Keon, {Hee Yoo} and Young, {Sook Yim} and Jaewon Choi and Soo, {Hyun Lee} and Hye, {Lim Jung} and Ki, {Woong Sung} and Yang, {Sung Eun} and Won, {Il Oh} and Yang, {Yoon Sun} and Kim, {Sang Hee} and Sang-Yun Choi and Hong, {Hoe Koo}",
year = "2006",
month = "12",
day = "1",
language = "English",
volume = "21",
pages = "1000--1004",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "6",

}

TY - JOUR

T1 - Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice

AU - Dong, Hyun Kim

AU - Keon, Hee Yoo

AU - Young, Sook Yim

AU - Choi, Jaewon

AU - Soo, Hyun Lee

AU - Hye, Lim Jung

AU - Ki, Woong Sung

AU - Yang, Sung Eun

AU - Won, Il Oh

AU - Yang, Yoon Sun

AU - Kim, Sang Hee

AU - Choi, Sang-Yun

AU - Hong, Hoe Koo

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Transplantation of marrow-derived mesenchymal stem cells (MSCs), expanded by culture in addition to whole bone marrow, has been shown to enhance engraftment of human hematopoietic stem cells (HSCs). Our hypothesis was that there might be an optimum ratio range that could enhance engraftment. We examined the percent donor chimerism according to the ratio of HSCs to MSCs in non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. We tested a series of ratios of co-transplanted CD34+-selected bone marrow cells, and marrow-derived MSCs into sublethally irradiated NOD/SCID mice. In all experiments, 1 × 105 bone marrow derived human CD34 + cells were administered to each mouse and human MSCs from different donors were infused concomitantly. We repeated the procedure three times and evaluated engraftment with flow cytometry four weeks after each transplantation. Serial ratios of HSCs to MSCs were 1:0, 1:1, 1:2 and 1:4, in the first experiment, 1:0, 1:1, 1:2, 1:4 and 1:8 in the second and 1:0, 1:1, 1:4, 1:8 and 1:16 in the third. Cotransplantation of HSCs and MSCs enhanced engraftment as the dose of MSCs increased. Our results suggest that the optimal ratio of HSCs and MSCs for cotransplantation might be in the range of 1:8-1:16; whereas, an excessive dose of MSCs might decrease engraftment efficiency.

AB - Transplantation of marrow-derived mesenchymal stem cells (MSCs), expanded by culture in addition to whole bone marrow, has been shown to enhance engraftment of human hematopoietic stem cells (HSCs). Our hypothesis was that there might be an optimum ratio range that could enhance engraftment. We examined the percent donor chimerism according to the ratio of HSCs to MSCs in non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice. We tested a series of ratios of co-transplanted CD34+-selected bone marrow cells, and marrow-derived MSCs into sublethally irradiated NOD/SCID mice. In all experiments, 1 × 105 bone marrow derived human CD34 + cells were administered to each mouse and human MSCs from different donors were infused concomitantly. We repeated the procedure three times and evaluated engraftment with flow cytometry four weeks after each transplantation. Serial ratios of HSCs to MSCs were 1:0, 1:1, 1:2 and 1:4, in the first experiment, 1:0, 1:1, 1:2, 1:4 and 1:8 in the second and 1:0, 1:1, 1:4, 1:8 and 1:16 in the third. Cotransplantation of HSCs and MSCs enhanced engraftment as the dose of MSCs increased. Our results suggest that the optimal ratio of HSCs and MSCs for cotransplantation might be in the range of 1:8-1:16; whereas, an excessive dose of MSCs might decrease engraftment efficiency.

KW - Engraftment

KW - Hematopoietic stem cells

KW - Mesenchymal stem cells

KW - Mice, SCID

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=33845887253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845887253&partnerID=8YFLogxK

M3 - Article

C2 - 17179676

AN - SCOPUS:33845887253

VL - 21

SP - 1000

EP - 1004

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 6

ER -